# Liraglutide LEADER trial: heart outcomes in type 2 diabetes

Source: https://pepvault.app/research/liraglutide-leader-2016

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Liraglutide](https://pepvault.app/research#liraglutide)

Randomized trial · people

# Liraglutide: 13.0% vs 14.9% major cardiovascular events in LEADER

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In people with type 2 diabetes and high heart risk, liraglutide lowered the combined rate of heart-related death, heart attack and stroke compared with placebo over a median of 3.8 years.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 9340
- **Published:** 2016
- **Journal:** N Engl J Med

## What they tested

The team tested whether adding liraglutide to usual care in type 2 diabetes was at least as safe for the heart as placebo, and whether it lowered heart events.

## How the study was done

A double-blind, randomized, placebo-controlled trial (placebo, a dummy treatment) in 9340 people with type 2 diabetes and high cardiovascular risk, followed for a median of 3.8 years. The main outcome was the first of three events: death from cardiovascular causes, a nonfatal heart attack (myocardial infarction) or a nonfatal stroke.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking liraglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

The main outcome occurred in 608 of 4668 people on liraglutide (13.0%) and 694 of 4672 on placebo (14.9%), a hazard ratio of 0.87 (95% CI 0.78 to 0.97). This met the bar for being no worse than placebo (P<0.001) and also for being better (P=0.01). Cardiovascular death was lower with liraglutide (4.7% vs 6.0%; hazard ratio 0.78), and so was death from any cause (8.2% vs 9.6%; hazard ratio 0.85). Nonfatal heart attack, nonfatal stroke and hospital stays for heart failure were lower with liraglutide, but not significantly, and gastrointestinal events were the most common reason people stopped the drug.

## What it doesn’t show

The trial only enrolled people with type 2 diabetes at high cardiovascular risk, and the prespecified exploratory outcomes were not adjusted for testing many outcomes at once. It was funded by Novo Nordisk and the National Institutes of Health.

## The paper

Marso et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016.

- [PubMed (PMID 27295427)](https://pubmed.ncbi.nlm.nih.gov/27295427/)
- [The paper (DOI 10.1056/NEJMoa1603827)](https://doi.org/10.1056/NEJMoa1603827)
- [ClinicalTrials.gov (NCT01179048)](https://clinicaltrials.gov/study/NCT01179048)

## The compound

- [Liraglutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/liraglutide)
- [Liraglutide dose guide](https://pepvault.app/lab/dosage/liraglutide)

## With this study

### Liraglutide

- [Liraglutide: the full reference](https://pepvault.app/peptides/liraglutide)
- [Liraglutide dose guide](https://pepvault.app/lab/dosage/liraglutide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/liraglutide-10mg)

### Studies

- [Liraglutide: 6.4% weight loss vs 15.8% on semaglutide in STEP 8](https://pepvault.app/research/liraglutide-step-8-2022)
- [Liraglutide plus exercise: 9.5 kg more loss than placebo at 1 year](https://pepvault.app/research/liraglutide-lundgren-2021)
- [All 4 studies](https://pepvault.app/research#liraglutide)

### Compared with

- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on Liraglutide

- [Liraglutide: 6.4% weight loss vs 15.8% on semaglutide in STEP 8](https://pepvault.app/research/liraglutide-step-8-2022) Randomized trial · people · 2022
- [Liraglutide plus exercise: 9.5 kg more loss than placebo at 1 year](https://pepvault.app/research/liraglutide-lundgren-2021) Randomized trial · people · 2021
- [Liraglutide: 8.4 kg lost vs 2.8 kg on placebo at 56 weeks](https://pepvault.app/research/liraglutide-scale-obesity-and-prediabetes-2015) Randomized trial · people · 2015
- [Every study on Liraglutide](https://pepvault.app/research#liraglutide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking liraglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking liraglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Liraglutide

- [Liraglutide: the full reference](https://pepvault.app/peptides/liraglutide)
- [Liraglutide dose guide](https://pepvault.app/lab/dosage/liraglutide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/liraglutide-10mg)

### Studies

- [Liraglutide: 6.4% weight loss vs 15.8% on semaglutide in STEP 8](https://pepvault.app/research/liraglutide-step-8-2022)
- [Liraglutide plus exercise: 9.5 kg more loss than placebo at 1 year](https://pepvault.app/research/liraglutide-lundgren-2021)
- [All 4 studies](https://pepvault.app/research#liraglutide)

### Compared with

- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking liraglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Liraglutide](https://pepvault.app/research#liraglutide)

## The library

- [Liraglutide](https://pepvault.app/peptides/liraglutide)
- [Liraglutide dose guide](https://pepvault.app/lab/dosage/liraglutide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Victoza and Trulicity are trademarks of their respective owners; PepVault is independent and not affiliated with or endorsed by any manufacturer.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
